Histofi
Histofi is a cancer care technology company that simplifies and democratizes access to advanced cancer diagnostics and treatments globally. Their AI-driven platform, Histofi Platform, digitizes the entire pathology workflow, from sample collection to AI analysis, making advanced cancer care accessible even in underserved regions. They offer services like Digital Pathology, Diagnostic AI Applications, Telepathology for second opinions, Tumor Board consultations, and Molecular Pathology. Their approach is patient-centric and provider-friendly, aiming to shorten diagnosis time, improve accuracy, and enhance patient outcomes through AI and a connected care continuum. Histofi's business model is SaaS and PaaS, providing tools and AI applications at no cost with minimal training for providers, focusing on a global distribution of scientific resources in cancer care.
Histofi
Histofi is a cancer care technology company that simplifies and democratizes access to advanced cancer diagnostics and treatments globally. Their AI-driven platform, Histofi Platform, digitizes the entire pathology workflow, from sample collection to AI analysis, making advanced cancer care accessible even in underserved regions. They offer services like Digital Pathology, Diagnostic AI Applications, Telepathology for second opinions, Tumor Board consultations, and Molecular Pathology. Their approach is patient-centric and provider-friendly, aiming to shorten diagnosis time, improve accuracy, and enhance patient outcomes through AI and a connected care continuum. Histofi's business model is SaaS and PaaS, providing tools and AI applications at no cost with minimal training for providers, focusing on a global distribution of scientific resources in cancer care.
TL;DR
Sector: Digital health / MedTech (cancer diagnostics & care)
Founded: 2019
Headquarters: Irvine / Los Angeles, California, USA
Product: AI-driven digital pathology platform (SaaS/PaaS) for cancer diagnostics and care
Last disclosed funding: Non-equity assistance, June 28, 2021
Company Overview
Problem Domain
Cancer diagnosis and treatment decision support; limited access to advanced diagnostics in underserved regions.
Founded
2019
Industry
Digital health / MedTech
Funding Track Record
Last disclosed funding event per public profiles
Investor Signal
“MassChallenge (non-equity assistance)”